`
`Paper No.
`Filed: February 2, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED
`Petitioners,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD.
`Patent Owner
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Kaken Pharmaceutical Co., Ltd.
`
`Case IPR2017-00190
`Patent No. 7,214,506
`
`
`provides the following updated mandatory notices to identify the following
`
`administrative matter filed January 12, 2017:
`
`Reissue Control No. 12/405,171 (U.S. Patent No. 7,214,506) (pending).
`
`
`
`Dated: February 2, 2017
`
`Respectfully submitted,
`
`
`
`By: /John D. Livingstone/
`John D. Livingstone
`Reg. No. 59,613
`FINNEGAN, HENDERSON, FARABOW,
` GARRETT & DUNNER, LLP
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`404-653-6400
`
`Lead Counsel for Patent Owner
`
`1
`
`
`
`CERTIFICATE OF SERVICE
`
`Case IPR2016-00952
`Patent No. 9,121,412
`
`
`The undersigned certifies that a copy of the foregoing Patent Owner’s
`
`Updated Mandatory Notices was served electronically via email on February 2,
`
`2017, in its entirety on the following:
`
`E. Anthony Figg
`efigg@rothwellfigg.com
`Rothwell, Figg, Ernst & Manbeck, P.C.
`607 14th Street, N.W., Suite 800
`Washington, DC 20005
`
`Aydin H. Harston
`aharston@rothwellfigg.com
`Rothwell, Figg, Ernst & Manbeck, P.C.
`607 14th Street, N.W., Suite 800
`Washington, DC 20005
`
`
`
`By: /Valencia Daniel/
`Valencia Daniel
`Litigation Legal Assistant
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`
`
`
`
`
`
`
`
`